Azathioprine in Recurrent Implantation Failure

• Status: Completed
• Trial end date: 2019-07-01
• Target enrollment: 0
• Participant gender: Female

Summary

Azathioprine increase pregnancy rate in patients with recurrent implantation failure

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Ain Shams University
• Collaborator: Capital Birth Center
• Treatments: Azathioprine

Criteria

Inclusion Criteria:

• age: 20-39

• previous 3 or more failed ivf

Exclusion Criteria:

• intrauterine anomalies

• chronic systemic illness

• chronic pelvic conditions

• sensitivety to azathioprine